NFE2L2 and Alzheimer disease: Bahn et al.’s study of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) revealed that Nrf2 inhibits BACE1, a rate-limiting enzyme for Aβ peptides in AD model mouse, by binding to the are promoter of BACE1 [37,41].